Intrexon | XON - Nakit Ve Eşdeğer





Nakit Ve Eşdeğer Değişiklik Tarih
Agenus USD 3.46M 6.08M 2025-09
Alaunos Therapeutics USD 1.38M 553K 2025-12
Amgen USD 12.04B 2.91B 2026-03
Anika Therapeutics USD 41.02M 16.46M 2026-03
Arrowhead Research USD 201.64M 112.94M 2025-12
AstraZeneca USD 7.56B 1.85B 2026-03
Bristol-Myers Squibb USD 9.57B 635M 2026-03
Gilead Sciences USD 7.56B 234M 2025-12
GlaxoSmithKline GBP 3.44B 292M 2026-03
Heron Therapeutics USD 43.07M 26.55M 2025-09
Incyte USD 4.02B 435.22M 2026-03
Intrexon USD 9.34M 1.77M 2024-06
Karyopharm Therapeutics USD 60.54M 22.87M 2025-12
Ligand Pharmaceuticals USD 174.93M 489.59M 2025-12
MacroGenics USD 57.22M 22.91M 2025-12
MannKind USD 74.88M 52.51M 2025-12
Merck USD 5.33B 9.24B 2026-03
Novartis USD 6.88B 4.56B 2026-03
Rigel Pharmaceuticals USD 48.53M 4.87M 2025-09
Roche Holding CHF 7.55B 579M 2025-06
Sangamo BioSciences USD 38.34M 13.16M 2025-06
Thermo Fisher Scientific USD 3.25B 6.6B 2026-03
Veracyte USD 362.58M 47M 2025-12
Xencor USD 54.07M 25.78M 2025-12